# TYME TECHNOLOGIES, INC.: Form D filing

TYME TECHNOLOGIES, INC., a pharmaceuticals company in New York, NY, filed a Form D with the SEC in 2020. The latest, on January 21, 2020, reports $20 million sold of a $20 million offering to 1 investor.

Find out what TYME TECHNOLOGIES, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20TYME%20TECHNOLOGIES%2C%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=TYME%20TECHNOLOGIES%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Ftyme-technologies-inc-1537917)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20TYME%20TECHNOLOGIES%2C%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=TYME%20TECHNOLOGIES%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Ftyme-technologies-inc-1537917)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 17 STATE STREET, 7TH FLOOR, New York, NY, 10004
- Phone: (212) 461-2315
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1537917

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 21, 2020 | New notice | $20,000,000 | $20,000,000 | $0 | 1 | Jan 7, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1537917/000156020820000003/0001560208-20-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Barbara Galani | Executive Officer |  |
| Paul H. Sturman | Director |  |
| Tommy G. Thompson | Director |  |
| Ben R. Taylor | Executive Officer |  |
| Giuseppe R. Del Priore | Executive Officer |  |
| Jonathan R. Eckard | Executive Officer |  |
| Timothy C. Tyson | Director |  |
| David R. Carberry | Director |  |
| Gerald H. Sokol | Director |  |
| Steve Hoffman | Executive Officer, Director |  |
| Donald DeGolyer | Director |  |
| Douglas Michels | Director |  |
| Michele R. Korfin | Executive Officer |  |

## Other pharmaceuticals companies in New York that filed recently

- [NBO Pharma Inc.](https://specstream.ai/data/form-d/company/nbo-pharma-inc-2103906) $238,000 · Nov 9, 2026
- [Pierrepont Therapeutics, Inc.](https://specstream.ai/data/form-d/company/pierrepont-therapeutics-inc-2019360) $2.4 million · Sep 22, 2026

[Every Form D from the week of Jan 20, 2020](https://specstream.ai/data/form-d/week/2020-01-20) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what TYME TECHNOLOGIES, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).